Login

Veradigm Inc. 8-K SEC Filings

Filed On Filing
15 Sep 2026 8-K: Regulation FD Disclosure

Investor Deck September 2026 VDMT-2697-AUG-2026 Exhibit 99.1

08 Sep 2026 8-K: Other Events

Veradigm Inc. (the “Company”) recently learned that one of its third-party vendors experienced a cybersecurity incident that impacted certain data associated with a small number of the Company’s customers. Based on the Company’s investig...

08 Sep 2026 8-K: Regulation FD Disclosure

Veradigm Announces Updated Presentation Time for Upcoming Investor Conference

17 Aug 2026 8-K: Regulation FD Disclosure

Veradigm to Participate in Two Upcoming Investor Conferences

26 Jun 2026 8-K: Other Events

As previously disclosed, on July 26, 2024, Veradigm Inc. (the “Company”) entered into a Stockholder Agreement (the “Stockholder Agreement”) with Charles Myers (“Myers”) and Jessica Myers (together with Myers, the “Myers Parties”), pursua...

26 May 2026 8-K: Results of Operations and Financial Condition

CHICAGO – May 26, 2026 – Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Report on Form 10-K for the years ended Dece...

06 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

1.1. Purposes. The purposes of the Veradigm Inc. Second Amended and Restated 2024 Stock Incentive Plan (this “Plan”) are (i) to align the interests of the Company’s stockholders and the recipients of awards under this Plan by increasing ...

24 Feb 2026 8-K: Other Events

On February 20, 2026, Veradigm Inc. (the “Company”) received a letter from the Division of Enforcement of the U.S. Securities and Exchange Commission (the “SEC”) stating that it has concluded its investigation as to the Company and, base...

17 Feb 2026 8-K: Results of Operations and Financial Condition

CHICAGO – February 17, 2026 – Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strateg...

02 Feb 2026 8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +1 more

This Amendment No. 6 to Stockholder Rights Agreement (this “Amendment”) is made and entered into as of February 2, 2026, by and between Veradigm Inc., a Delaware corporation (the “Company”), and Broadridge Corporate Issuer Solutions, LLC...

20 Jan 2026 8-K: Entry into a Material Definitive Agreement

This AMENDMENT (this “Amendment”), dated as of January 15, 2026, is by and among Veradigm Inc. (the “Company”), Charles Myers (“Myers”) and Jessica Myers (together with Myers, the “Myers Parties”). Each of the Company, on the one hand, a...

31 Dec 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

This letter confirms our mutual agreement to extend the term of your employment as Interim Chief Financial Officer and Interim Chief Accounting Officer of Veradigm Inc. (the “Company”) under the Letter Agreement, dated December 7, 2023, ...

30 Sep 2025 8-K: Results of Operations and Financial Condition

CHICAGO – September 30, 2025 – Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing estimated financial performance for the second quarter of 2025 compared to the prior year, details abo...

29 Sep 2025 8-K: Other Events

Veradigm Inc. (the “Company”) entered into a repurchase agreement (the “Repurchase Agreement”) with a certain holder of the Company’s 0.875% Convertible Senior Notes due 2027 (the “Convertible Notes”), for itself and on behalf of certain...

20 Aug 2025 8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +1 more

This Amendment No. 5 to Stockholder Rights Agreement (this “Amendment”) is made and entered into as of August 20, 2025, by and between Veradigm Inc., a Delaware corporation (the “Company”), and Broadridge Corporate Issuer Solutions, LLC,...

18 Aug 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made this 15th day of August, 2025 (the “Signing Date”) and effective as of September 2, 2025 (the “Effective Date”), by and between Veradigm Inc., a corporation organized and existing unde...

24 Jul 2025 8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more

This AMENDMENT (this “Amendment”), dated as of July 24, 2025, is by and among Veradigm Inc. (the “Company”), Charles Myers (“Myers”) and Jessica Myers (together with Myers, the “Myers Parties”). Each of the Company, on the one hand, and ...

02 Jul 2025 8-K: Triggering Events That Accelerate a Financial Obligation

On June 30, 2025, Veradigm Inc., a Delaware corporation (the “Company”), received a notice from U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, as trustee (the “Trustee”), pursua...

23 Jun 2025 8-K: Results of Operations and Financial Condition

CHICAGO – June 23, 2025 – Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing an update on commercial activity and estimated financial performance for the first quarter of 2025 compared...

20 Jun 2025 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

THE LOANS ISSUED PURSUANT TO THIS AGREEMENT WERE ISSUED WITH ORIGINAL ISSUE DISCOUNT FOR PURPOSES OF SECTION 1271 ET SEQ. OF THE UNITED STATES INTERNAL REVENUE CODE OF 1986, AS AMENDED FROM TIME TO TIME. BEGINNING NOT LATER THAN 10 DAYS ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support